Neuromuscular diseases affect the nerves and muscles responsible for movement, strength, and daily functioning. Although many of these conditions remain challenging to treat, ongoing scientific . . .
Progressive muscle disorders encompass various conditions that gradually reduce muscle strength, endurance, and physical function. These disorders may result from inherited genetic changes, autoimmune conditions, . . .
Rare diseases affect millions of people worldwide, although each individual condition is relatively uncommon. Many rare diseases have a genetic origin, making advances in genetic research essential for improving . . .
Living with Duchenne Muscular Dystrophy (DMD) presents unique challenges for both individuals and their families. DMD is a genetic condition that causes progressive muscle weakness . . .
Duchenne Muscular Dystrophy (DMD) is a genetic condition that causes progressive muscle weakness over time. Rehabilitation and physical therapy are important components of long-term care . . .
Genetic testing is a valuable tool for confirming Duchenne Muscular Dystrophy (DMD), a genetic condition that primarily affects muscle function. Since DMD is caused by . . .
Exon skipping treatment has become an important advancement in the management of Duchenne Muscular Dystrophy (DMD), offering a targeted approach for patients with specific genetic . . .
Clinical trials are carefully planned research studies that evaluate new treatments, medications, medical devices, or care strategies for specific health conditions. For individuals with Duchenne . . .
Duchenne Muscular Dystrophy is a rare inherited disorder caused by mutations in the dystrophin gene, leading to progressive muscle weakness over time. Traditional treatment focuses . . .
Duchenne Muscular Dystrophy (DMD) is a rare genetic disorder that primarily affects muscle strength and function. It develops because of changes in the dystrophin gene, leading to . . .